CHRONIC HEPATITIS B-RELATED LIVER FIBROSIS
Clinical trials for CHRONIC HEPATITIS B-RELATED LIVER FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B-RELATED LIVER FIBROSIS trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B-RELATED LIVER FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to halt liver damage from hepatitis b
Disease control Not yet recruitingThis study is testing the safety of a new oral medication called Hydronidone in people with liver scarring caused by chronic hepatitis B. The main goal is to see how well the drug is tolerated and to check for side effects. All 150 participants will take the drug for 28 days whil…
Matched conditions: CHRONIC HEPATITIS B-RELATED LIVER FIBROSIS
Phase: PHASE2 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
Scientists trace radioactive Drug's path in healthy volunteers
Knowledge-focused Not yet recruitingThis is an early, small study to understand how the body processes a drug called Hydronidone, which is being developed for liver scarring from hepatitis B. Eight healthy Chinese men will receive a single dose containing a tiny, safe amount of radioactive tracer. Researchers will …
Matched conditions: CHRONIC HEPATITIS B-RELATED LIVER FIBROSIS
Phase: PHASE1 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC